|
Volumn 12, Issue 2, 2005, Pages 223-224
|
Testicular natural killer T-cell lymphoma
|
Author keywords
Killer cells; Lymphoma; T cell; Testicular neoplasms
|
Indexed keywords
BLEOMYCIN;
CD2 ANTIGEN;
CD3 ANTIGEN;
CD3EPSILON ANTIGEN;
CD56 ANTIGEN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
METHOTREXATE;
UNCLASSIFIED DRUG;
VINDESINE;
ADULT;
ARTICLE;
CANCER GROWTH;
CASE REPORT;
CAUCASIAN;
DEATH;
FRANCE;
HUMAN;
HUMAN TISSUE;
IMMUNOPHENOTYPING;
MALE;
PRIORITY JOURNAL;
PROGNOSIS;
T CELL LYMPHOMA;
TESTICULAR NATURAL KILLER T CELL LYMPHOMA;
TESTIS CANCER;
ADULT;
ANTIBODIES;
ANTIGENS, CD;
ANTIGENS, CD43;
ANTIGENS, CD56;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
FATAL OUTCOME;
HUMANS;
INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS;
KILLER CELLS, NATURAL;
LYMPHOMA, T-CELL;
MALE;
ORCHIECTOMY;
SIALOGLYCOPROTEINS;
TESTICULAR NEOPLASMS;
|
EID: 16244414027
PISSN: 09198172
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1442-2042.2005.01007.x Document Type: Article |
Times cited : (20)
|
References (6)
|